{"url":"https://newsforagent.com/news/2026-10-26/medifast-q3-2026-revenue-net-loss","markdown_url":"https://newsforagent.com/news/2026-10-26/medifast-q3-2026-revenue-net-loss.md","title":"Medifast Posts $72 Million Quarter as Coaches Fall 47.7%","headline":"Medifast Reports $72 Million in Q3 Revenue and a $17.5 Million Net Loss as Active Coaches Drop 47.7%","description":"Medifast reported $72.0 million in third-quarter 2026 revenue, down 19.4%, and a $17.5 million net loss as active earning coaches fell 47.7% to 10,200.","section":"Earnings & Results","published_at":"2026-10-26T12:30:04+00:00","modified_at":"2026-10-26T12:30:04+00:00","author":"News Desk","key_takeaways":["Medifast revenue fell 19.4% to $72.0 million in the third quarter of 2026, with a net loss of $17.5 million.","Independent active earning coaches dropped 47.7% to 10,200, while revenue per active earning coach rose 54.1% to $7,064.","Medifast guided fourth-quarter 2026 revenue to $55 million to $75 million and full-year revenue to $280 million to $300 million."],"companies":[{"name":"Medifast","is_primary":true,"profile_url":"https://akta.pro/company-profiles/000wh2t/medifast","website":"https://medifastinc.com"}],"source":{"publisher":"Business Wire","title":"Medifast Announces Third Quarter 2026 Financial Results","url":"https://www.businesswire.com/news/home/20261026870184/en/"},"other_sources":[],"tags":["Earnings & Results","Medifast"],"body_markdown":"[Medifast](https://akta.pro/company-profiles/000wh2t/medifast) reported third-quarter 2026 revenue of $72.0 million, down 19.4% from $89.4 million a year earlier, and a net loss of $17.5 million, or $1.57 per diluted share. The company said independent active earning coaches fell 47.7% to 10,200 from 19,500. The announcement was distributed by [Business Wire](https://www.businesswire.com/news/home/20261026870184/en/).\n\n## Medifast's Third Quarter Results and Coach Decline\n\nMedifast is a Baltimore-based health and wellness company that sells OPTAVIA meal replacement products, structured weight-management plans and coach-guided metabolic health support through independent coaches and direct-to-consumer e-commerce. The company said the revenue decline was primarily driven by the decrease in the number of active earning coaches, which it attributed to continued pressure with client acquisition reflecting broader challenges in the operating environment, including rapid adoption of GLP-1 medications for weight loss.\n\nAverage revenue per active earning coach was $7,064, compared with $4,585 for the third quarter last year, an increase of 54.1%. Medifast said it expects the number of active earning coaches to continue to decline through the end of 2026.\n\nGross profit decreased 19.5% to $50.0 million from $62.2 million, and gross profit margin was 69.5% for both periods. Selling, general and administrative expenses increased 4.8% to $69.4 million, primarily due to a $13.8 million increase for Catalyst Restructuring charges. The company said its loss from operations was $19.4 million, compared with $4.1 million a year earlier.\n\nNick Johnson, Medifast's Chief Executive Officer, said, \"The third quarter was about execution. With Trilivy now live, Reset Fuelings in our coaches' hands, and our new compensation plan and Coach Hub launched, the major pieces of our 3.0 strategy are now in market.\"\n\n## Medifast's Cash Position and Guidance\n\nMedifast held cash, cash equivalents and investment securities of $172.5 million with no debt as of September 30, 2026, compared with $167.3 million at December 31, 2025, according to akta.pro [company records](https://akta.pro/company-data). The company expects fourth-quarter 2026 revenue of $55 million to $75 million and full-year 2026 revenue of $280 million to $300 million. Fourth-quarter 2026 income per share is guided to $0.00 to $0.25, and full-year 2026 loss per share to $1.80 to $2.05.\n\n## Medifast's Path to the Third Quarter\n\nMedifast announced the launch of the Medifast Metabolic Health Institute on August 27, 2026, a centralized hub for evidence-based research and education in metabolic health, according to Stock Titan. On October 14, 2026, the company said it would announce its third-quarter results on October 26, 2026, before market open, with a conference call hosted by CEO Nick Johnson and CFO Jim Maloney, according to Stock Titan. Medifast reported second-quarter 2026 EPS of -$0.28, beating the -$0.65 consensus, with revenue of $76.38 million, according to American Banking and Market News.\n\n## Medifast's Fourth Quarter Call and Webcast\n\nThe company said the conference call is scheduled for October 26, 2026 at 8:30 a.m. ET, with the webcast archived online and available through January 26, 2027.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}